您当前所在的位置:首页 > 产品中心 > 产品信息
Amcinonide_分子结构_CAS_51022-69-6)
点击图片或这里关闭

Amcinonide

产品号 DB00288 公司名称 DrugBank
CAS号 51022-69-6 公司网站 http://www.ualberta.ca/
分子式 C28H35FO7 电 话 (780) 492-3111
分子量 502.5717032 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 173

产品价格信息

请登录

产品别名

标题
Amcinonide
IUPAC标准名
2-[(1'S,2'S,4'R,8'S,9'S,11'S,12'R,13'S)-12'-fluoro-11'-hydroxy-9',13'-dimethyl-16'-oxo-5',7'-dioxaspiro[cyclopentane-1,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-14',17'-dien-8'-yl]-2-oxoethyl acetate
IUPAC传统名
cyclocort
商标名
Cyclocort

产品登记号

CAS号 51022-69-6
PubChem CID 443958
PubChem SID 46506705

产品性质

疏水性(logP) 2.3

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Amcinonide is a corticosteroid. [Wikipedia]
Indication For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Pharmacology Amcinonide is a topical corticosteroid. The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Amcinonide reduces or inhibits the actions of chemicals in the body that cause inflammation, redness, and swelling. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. When in an ointment form, amcinonide also helps the skin maintain moisture.
Toxicity Results from acute toxicity studies do not indicate that any risk of acute intoxication is to be expected following a single dermal application of an overdose (application over a large area under conditions favorable to absorption) or inadvertent oral ingestion.
Affected Organisms
Humans and other mammals
Biotransformation Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys.
Absorption Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption.
Elimination Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys.
Some of the topical corticosteroids and their metabolites are also excreted into the bile.
External Links
Wikipedia
RxList
PDRhealth
Drugs.com

参考文献